Kiora Pharmaceuticals, Inc. (KPRX)
2.29
-0.03
(-1.29%)
USD |
NASDAQ |
Oct 23, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Kiora Pharmaceuticals EPS Diluted (Quarterly) : -0.3365 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3365 |
| March 31, 2026 | -0.5792 |
| December 31, 2025 | -1.732 |
| September 30, 2025 | 0.0062 |
| June 30, 2025 | -0.5396 |
| March 31, 2025 | -0.52 |
| December 31, 2024 | -1.408 |
| September 30, 2024 | -0.8098 |
| June 30, 2024 | -0.5327 |
| March 31, 2024 | 3.457 |
| December 31, 2023 | -2.650 |
| September 30, 2023 | -7.970 |
| June 30, 2023 | -7.151 |
| March 31, 2023 | -9.024 |
| December 31, 2022 | -12.52 |
| September 30, 2022 | -54.30 |
| June 30, 2022 | -66.15 |
| March 31, 2022 | -98.28 |
| December 31, 2021 | -163.56 |
| September 30, 2021 | -4082.87 |
| June 30, 2021 | -122.62 |
| March 31, 2021 | -98.37 |
| December 31, 2020 | -87.52 |
| September 30, 2020 | -158.87 |
| June 30, 2020 | -136.17 |
| Date | Value |
|---|---|
| March 31, 2020 | -155.32 |
| December 31, 2019 | -272.51 |
| September 30, 2019 | -413.75 |
| June 30, 2019 | -226.53 |
| March 31, 2019 | 69.71 |
| December 31, 2018 | -311.74 |
| September 30, 2018 | -390.58 |
| June 30, 2018 | -400.52 |
| March 31, 2018 | -744.50 |
| December 31, 2017 | -885.87 |
| September 30, 2017 | -1296.00 |
| June 30, 2017 | -1512.00 |
| March 31, 2017 | -1512.00 |
| December 31, 2016 | -2052.00 |
| September 30, 2016 | -1944.00 |
| June 30, 2016 | -2484.00 |
| March 31, 2016 | -1674.00 |
| December 31, 2015 | -1897.02 |
| September 30, 2015 | -1026.00 |
| June 30, 2015 | -1296.00 |
| March 31, 2015 | -3382.78 |
| December 31, 2014 | -127.76 |
| September 30, 2014 | 94.99 |
| June 30, 2014 | -594.00 |
| March 31, 2014 | -810.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 0.0858 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.079M |
| Total Expenses (Quarterly) | 2.079M |
| Enterprise Value | -6.367M |
| Earnings Yield | -115.4% |
| Normalized Earnings Yield | -88.90 |